IAHT Platform

About Kaio Therapy

Kaio Therapy is a private, preclinical-stage biotech developing a novel hyperthermia-based immunotherapy platform. Its lead technology, Immune Activating Heat Therapy (IAHT), uses injected magnetic nanoparticles and an alternating magnetic field device to generate precise heat within tumors, aiming to induce necrosis and trigger a systemic, tumor-specific immune response. The company is initially targeting cutaneous tumors but anticipates expansion to other solid tumors like breast and head and neck cancers. Kaio Therapy's strategy positions IAHT both as a standalone therapy and as a potential platform to enhance other immunotherapies.

About Kaio Therapy

Kaio Therapy is a private, preclinical-stage biotech developing a novel hyperthermia-based immunotherapy platform. Its lead technology, Immune Activating Heat Therapy (IAHT), uses injected magnetic nanoparticles and an alternating magnetic field device to generate precise heat within tumors, aiming to induce necrosis and trigger a systemic, tumor-specific immune response. The company is initially targeting cutaneous tumors but anticipates expansion to other solid tumors like breast and head and neck cancers. Kaio Therapy's strategy positions IAHT both as a standalone therapy and as a potential platform to enhance other immunotherapies.

About Kaio Therapy

Kaio Therapy is a private, preclinical-stage biotech developing a novel hyperthermia-based immunotherapy platform. Its lead technology, Immune Activating Heat Therapy (IAHT), uses injected magnetic nanoparticles and an alternating magnetic field device to generate precise heat within tumors, aiming to induce necrosis and trigger a systemic, tumor-specific immune response. The company is initially targeting cutaneous tumors but anticipates expansion to other solid tumors like breast and head and neck cancers. Kaio Therapy's strategy positions IAHT both as a standalone therapy and as a potential platform to enhance other immunotherapies.

Therapeutic Areas